Vertex Pharmaceuticals Incorporated Announces Webcast Of Its Presentation At The 24th Annual JPMorgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 4 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will webcast its corporate presentation at the 24th Annual JPMorgan Healthcare Conference in San Francisco, California. The presentation will be delivered by Joshua Boger, Ph.D., Vertex's Chairman, President and Chief Executive Officer on Monday, January 9, 2006, at 11:00 a.m. EST (8:00 a.m. PST).
The presentation will be webcast live and may be accessed by visiting Vertex's website at http://www.vrtx.com. A replay of the webcast will also be available on the Company's website until January 23, 2006. To access the webcast, go to Vertex's website and select '24th Annual JPMorgan Healthcare Conference.' To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex's press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations (617) 444-6755
Vertex Pharmaceuticals IncorporatedCONTACT: Lora Pike, Manager, Investor Relations of Vertex PharmaceuticalsIncorporated, +1-617-444-6755
Web site: http://www.vrtx.com/